Tageszeitungen (Symbolbild).
Dienstag, 21.06.2016 16:05 von GlobeNewswire | Aufrufe: 189

Change in Biotie Therapies' Financial Reporting Calendar 2016

Tageszeitungen (Symbolbild). pixabay.com

BIOTIE THERAPIES CORP.                STOCK EXCHANGE RELEASE             21 June 2016, at 5.00 p.m.

Change in Biotie Therapies' Financial Reporting Calendar 2016

Due to Biotie Therapies Corp. (Nasdaq Helsinki: BTH1V) ("Biotie" or "Company") aligning its financial reporting calendar with the financial reporting calendar of Acorda Therapeutics, Inc., the Company announces certain changes in its financial reporting calendar for the year 2016. Biotie will now publish its Interim Financial Report for January to June 2016 on 28 July, 2016; the previously announced date was 11 August 2016.

Turku, 21 June 2016

Biotie Therapies Corp.

Timo Veromaa
President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com

DISTRIBUTION:
www.biotie.com
Nasdaq Helsinki Ltd.
Main Media

About Biotie 

Anzeige

Aktie im Fokus

Kurse

Biotie Therapies
-  
0,00%
Biotie Therapies Chart

Biotie is a biopharmaceutical company focused on products for neurodegenerative and psychiatric disorders. Biotie's development has delivered Selincro (nalmefene) for alcohol dependence, which received European marketing authorization in 2013 and is currently being rolled out across Europe by partner H. Lundbeck A/S. The current development products include tozadenant for Parkinson's disease, which is in Phase 3 development, and two additional compounds which are in Phase 2 development for cognitive disorders including Parkinson's disease dementia, and primary sclerosing cholangitis (PSC), a rare fibrotic disease of the liver.

For more information, please visit www.biotie.com.




This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biotie Therapies Oyj via Globenewswire

HUG#2022196
Werbung

Mehr Nachrichten zur Biotie Therapies Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News

ARIVA.DE Redaktion Thumbnail
31.10.24 - ARIVA.DE Redaktion